5 employees
Fuse Biotherapeutics is a biotech company developing next-generation immune-modulating therapeutics for patients with cancers.
2021
$9.5M
from 3 investors over 3 rounds
Fuse Biotherapeutics raised $9.5M on November 15, 2021
Investors: Sirona Capital, Viva BioInnovator and 夏尔巴股权投资管理有限公司